IDOGEN — Idogen AB Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- SEK12.58m
- SEK9.60m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -27.6 | -32.7 | -26.8 | -38.9 | -47.8 |
Depreciation | |||||
Non-Cash Items | — | — | — | — | 0.141 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 16.2 | -8.18 | -2.58 | -2.75 | -4.09 |
Change in Accounts Receivable | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -10.4 | -35 | -28.1 | -40.2 | -50.7 |
Capital Expenditures | -2.88 | -0.11 | — | -0.51 | -1.64 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -0.831 | -0.513 | — | — | 1.71 |
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Cash from Investing Activities | -3.71 | -0.623 | — | -0.51 | 0.071 |
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 38.8 | 0 | 49.1 | 9.22 | 40.4 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 24.7 | -35.6 | 21 | -31.5 | -10.3 |